Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells.
about
Nucleic acid aptamers: an emerging frontier in cancer therapyMechanism of regulation of bcl-2 mRNA by nucleolin and A+U-rich element-binding factor 1 (AUF1)General cell-binding activity of intramolecular G-quadruplexes with parallel structureA Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer TherapyAptamer-conjugated Magnetic Nanoparticles as Targeted Magnetic Resonance Imaging Contrast Agent for Breast Cancer.Kruppel-like factor 4 is a novel mediator of Kallistatin in inhibiting endothelial inflammation via increased endothelial nitric-oxide synthase expression.Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization.Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein BiomarkersTargeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell typeNucleolin promotes in vitro translation of feline calicivirus genomic RNA.A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis.A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanismStructural requirements for the procoagulant activity of nucleic acids.Aptamer photoregulation in vivoAptamers: active targeting ligands for cancer diagnosis and therapyBiodistribution and in vivo toxicity of aptamer-loaded gold nanostars.Nucleolin down-regulation is involved in ADP-induced cell cycle arrest in S phase and cell apoptosis in vascular endothelial cells.Cell surface nucleolin facilitates enterovirus 71 binding and infection.Aptamer-labeled PLGA nanoparticles for targeting cancer cells.Human anti-nucleolin recombinant immunoagent for cancer therapy.Direct observation of nanoparticle-cancer cell nucleus interactions.Aptamer-mediated delivery of chemotherapy to pancreatic cancer cellsCotinine-conjugated aptamer/anti-cotinine antibody complexes as a novel affinity unit for use in biological assays.AS1411-conjugated gold nanospheres and their potential for breast cancer therapyInterplay between αvβ3 integrin and nucleolin regulates human endothelial and glioma cell migration.A Targeted DNAzyme-Nanocomposite Probe Equipped with Built-in Zn(2+) Arsenal for Combined Treatment of Gene Regulation and Drug DeliveryStudy of the Function of G-Rich Aptamers Selected for Lung AdenocarcinomaLipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles.Nucleolin interacts with the dengue virus capsid protein and plays a role in formation of infectious virus particles.Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors.Grafting aptamers onto gold nanostars increases in vitro efficacy in a wide range of cancer cell types.Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands.G-quadruplexes: targets and tools in anticancer drug design.Aptamers as targeted therapeutics: current potential and challenges.The G-quadruplex-forming aptamer AS1411 potently inhibits HIV-1 attachment to the host cell.Cell-specific aptamers as emerging therapeutics.Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.Self-assembled aptamer-based drug carriers for bispecific cytotoxicity to cancer cellsDNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics.Aptamer TY04 inhibits the growth of multiple myeloma cells via cell cycle arrest.
P2860
Q26849947-85CA2029-96F3-460B-93FF-D87F9D93F83AQ28383026-5C85413D-0A58-4938-8B31-5267A5F23769Q28487102-409D8C4B-C507-4B90-BE63-B44FF7F2686AQ28550592-E5FCDB1E-3E17-41E1-8C39-79BCC90EEA46Q31151661-E239A330-2B15-47DA-85C7-03941F621356Q33512668-F7C3EDBF-C32D-4D7A-B5EF-CE4C63EC1E6AQ33784401-48A6DDD7-A7F8-4571-B2AA-93BD20BE5031Q33832781-6E807E84-9BDA-4CC8-A7AA-8E92698B0C32Q33980633-60056B95-BBF0-4192-B41A-99430B8A4BC0Q34045720-996D88BC-EDEF-4239-822F-2879B42A977AQ34221688-B0241BBE-D0F3-454E-B3D3-4B4BB2D453ADQ34268342-01A1DF24-8320-44C9-A99A-5E9023300CD9Q34505358-BCA6FD72-CB86-4932-98B4-13948490927AQ34661329-B8207C3C-674F-4FF1-A766-A15E058A1FA9Q35086493-9EA28B9E-C9E0-4171-A71C-9A33867D2BA6Q35268464-8193FA4B-86ED-404D-BCA6-863587DD0A7EQ35308865-79A4F76E-D94D-4217-89BC-D66D43075EF1Q35641079-F2E16D3B-4B4E-4067-B689-84E5C05596B8Q35673856-848786A5-C5C2-4157-90C9-B46B4D0F2D1DQ35690196-E9260C55-374D-41E8-AAF5-4F2A86592416Q35914639-6E1E3AE9-6A8E-41CC-848B-90DE55CD34B4Q36298003-55935C38-6A40-4BE3-B66D-5A975BD64E72Q36301870-5C3AB32D-C470-462A-9DF3-E6AF1F00CCFCQ36355940-21EDE6E6-19B3-4E34-BF3E-945E376D5AB7Q36508636-1EC0B2B8-7764-44EC-AFAC-ADCBBA864365Q36666480-12EDFE6C-9C16-4D93-BBF5-BAF855A2C259Q37137822-71295DEF-8BB5-4116-A1D7-89800626811CQ37316779-F5E63AF0-6BFC-4F4D-B902-7052B1473BCBQ37336680-1DB7BDB8-C6B7-4934-84C4-B4CB2C81C172Q37525035-36DC5A6D-BD1F-4FE3-9811-566ABFFDCB5DQ37682675-F4FDF859-BEF7-43CA-B0C0-A86779CCC1F1Q37698301-A504F971-D1C1-4AB9-A742-5CB9DEAD2391Q37994254-2533FEB0-0971-4C95-8DE1-B15B52A0C376Q38290290-93578F95-2D0C-4F61-9E3F-65423BBA80D1Q38293009-1CD78511-3CD2-487E-A5F3-CBFC9870005BQ38302347-C078168D-C3AC-4034-A569-BABF2F7E91C7Q38311680-0B3CFAFF-8A7C-4D96-BC54-9D2E3DE88F02Q38326261-D86D5125-6576-4E23-BC0D-0B5821E08100Q38989650-2381D3A0-48FC-4B8C-AD20-67D6B2B37501Q38998989-552CE80E-FEB3-46EF-90BF-1E400C23119E
P2860
Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasma membrane nucleolin is a ...... 1411 in MV4-11 leukemia cells.
@en
Plasma membrane nucleolin is a ...... 1411 in MV4-11 leukemia cells.
@nl
type
label
Plasma membrane nucleolin is a ...... 1411 in MV4-11 leukemia cells.
@en
Plasma membrane nucleolin is a ...... 1411 in MV4-11 leukemia cells.
@nl
prefLabel
Plasma membrane nucleolin is a ...... 1411 in MV4-11 leukemia cells.
@en
Plasma membrane nucleolin is a ...... 1411 in MV4-11 leukemia cells.
@nl
P2093
P2860
P356
P1476
Plasma membrane nucleolin is a ...... 1411 in MV4-11 leukemia cells.
@en
P2093
Daniel J Fernandes
David Jones
Eleanor K Spicer
Nigel Courtenay-Luck
Sridharan Soundararajan
Vijayalakshmi Sridharan
Weiwei Chen
P2860
P304
P356
10.1124/MOL.109.055947
P577
2009-08-05T00:00:00Z